Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia

9 Oct 2020

Abstract excerpt

The critical question in the management of chronic myelomonocytic leukemia (CMML) is which patients may benefit from allogeneic hematopoietic cell transplantation (allo-HCT). Using ad hoc statistical analysis, we designed a multicenter retrospective study to determine outcomes in 261 patients age ≤70 years at diagnosis who underwent allo-HCT (n = 119) compared with those who did not (n = 142) according to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Lymphocytic Leukemia Research
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33039516
DOI: 10.1016/j.bbmt.2020.10.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic LeukemiaPMID 33039516Read ↗

Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemiaSemantic proximity Read ↗

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemiaSemantic proximity Read ↗

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.Semantic proximity Read ↗

A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation.Semantic proximity Read ↗

Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institutionSemantic proximity Read ↗

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSemantic proximity Read ↗

Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemiaSemantic proximity Read ↗

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.Semantic proximity Read ↗

Allogeneic stem cell transplantation for myelofibrosis in the modern era: single- center outcomes with DIPSS risk stratificationSemantic proximity Read ↗

Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer CenterSemantic proximity Read ↗

Cytogenetic risk stratification in chronic myelomonocytic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.